Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1

Journal of Medical Virology

Volumn 60, Issue 3, 2000, Pages 347-352

  Musiani, Monica ^a   Manaresi, Elisabetta ^b   Gallinella, Giorgio ^b   Venturoli, Simona ^b   Zuffi, Elisa ^b   Zerbini, Marialuisa ^b  

^a Institute of Microbiology   (Italy)

^b NONE

Author keywords

Immunoglobulin preparations; Recombinant peptides; VP1 unique portion

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; STRUCTURAL PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; IMMUNOREACTIVITY; NONHUMAN; PARVOVIRUS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CAPSID; CAPSID PROTEINS; EPITOPES; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PARVOVIRUS;

EID: 0033977740     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200003)60:3<347::AID-JMV15>3.0.CO;2-T     Document Type: Article

References (24)

1. Anderson LJ. 1997. Treatment and prevention of human parvovirus B19 disease. In: Anderson LJ, Young NS, editors. Human parvovirus B19. Monographs in Virology, Vol. 20. Basel: Karger, p 137-148.
2. Anderson S, Momoeda M, Kawase M, Kajigaya S, Young NS. 1995. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 206:626-632.
3. Bansal GP, Hatfield JA, Dunn FE, Kramer AA, Brady F, Riggin CH, Collett MS, Yoshimoto K, Kajigaya S, Young NS. 1993. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 167: 1034-1044.
4. Brown CS, Salimans MMM, Noteborn MHM, Weiland HT. 1990. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res 15:197-212.
5. Gallinella G, Musiani M, Zerbini M, Gentilomi G, Gibellini D, Venturoli S, La Placa M. 1993. Efficient parvovirus B19 DNA purification and molecular cloning. J Virol Methods 1:203-212.
6. Kajigaya S, Fujii H, Field A, Anderson S, Rosenfeld S, Anderson LJ, Shimada T, Young NS. 1991. Self assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci USA 88:4646-4650.
7. Kajigaya S, Momoeda M. 1997. Immune response to B19 infection. In: Anderson LJ, Young NS, editors. Human parvovirus B19. Monographs in Virology, Vol 20. Basel: Karger. p 120-136.
8. Kawase M, Momoeda M, Young NS, Kajigaya S. 1995. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 211:359-366
9. Kerr S, O'Keeffe G, Kilty C, Doyle S. 1999. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 57:179-185
10. Kurtzman GJ, Cohen B, Field AM, Oseas R, Blaese RM, Young NS. 1989. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84: 1114-1123.
11. Manaresi E, Gallinella G, Zerbini M, Venturoli S, Gentilomi G, Musiani M. 1999. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay. J Med Virol 57:174-178.
12. Morinet F, D'Auriol L, Tratschin JD, Galibert F. 1989. Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli. Recognition by IgM and IgG antibodies in human sera. J Gen Virol 70:3091-3097.
13. Musiani M, Azzi A, Zerbini M., Gibellini D, Venturoli S, Zakrzewska K, Re MC, Gentilomi G, Gallinella G, La Placa M. 1993. Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients. J Med Virol 40:157-160.
14. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. 1995. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 172:1360-1363.
15. Ozawa K, Ayub J, Hao YS, Kurtzman G, Shimada T, Young N. 1987. Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 61:2395-2406
16. Ozawa K, Young NS. 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol 61:2627-2630.
17. Palmer P, Pallier C, Leruez-Ville M, Deplanche M, Morinet F. 1996. Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins. Clin Diagn Lab Immunol 3:236-238.
18. Rosenfeld SJ, Yoshimoto K, Kajigaya S, Anderson S, Young NS, Field A, Warrener P, Bansal G, Collet MS. 1992. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Inv 89:2023-2029.
19. Saikawa T, Anderson S, Momoeda M, Kajigaya S, Young NS. 1993. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 67:3004-3009.
20. Schwartz TF, Roggendorf M, Deinhardt F. 1988. Human parvovirus B19, ELISA and immunoblot assay. J Virol Meth 20:155-168.
21. Söderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K. 1995. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 172:1431-1436
22. Söderlund M, Brown KE, Meurman O, Hedman K. 1992. Prokariotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol 30:305-311.
23. Zerbini M, Musiani M, Venturoli S, Gallinella G, Gibellini D, Gentilomi G, La Placa M. 1990. Rapid screening for B19 parvovirus DNA in clinical specimens with a digoxigenin-labeled DNA hybridization probe. J Clin Microbiol 28:2496-2499.
24. Zerbini M, Musiani M. 1999. Human parvoviruses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology, 7th ed. Washington, DC: American Society for Microbiology p 1089-1098.